US DEA calls for big increases in cannabis and psilocybin production for research

The US Drug Enforcement Agency (DEA) is calling for an increase in production of cannabis and psychedelics to supply federal research and clinical trials.

In a notice published on the US government’s daily journal the Federal Register, the DEA said the increase in production applied specifically to schedule I substances such as psilocybin, psilocin, cannabis and cannabis extracts.


Restricted content. Do you want to read more?